B. Braun Medical Inc.

B. Braun Medical Inc. announced update on the recall of contaminated lots of heparin products from company and the ongoing testing of the heparin supply in Canada. The presence of a contaminant in the active pharmaceutical ingredients of certain lots of B. Braun heparin products was first identified by Health Canada and communicated to Canadians on March 20, 2008. This contaminant has been found in the following specific products and lots, which are being recalled: Lot number: J7D580, J6N438, J6J492, J5P643 ; Description: Heparin Sodium 20,000 units in 5% Dextrose Injection, 500 mL and ; Drug Identification Number (DIN): 02209713. Lot number: J7E577 J6L669 J5S669 ; Description: Heparin Sodium 25,000 units in 5% Dextrose Injection, 500 mL and ; Drug Identification Number (DIN): 01935941. Lot number: J7E420, J6K645, J6H487; Description: Heparin Sodium 25,000 units in 5% Dextrose Injection, 250 mL and ; Drug Identification Number (DIN): 02209721. Lot number: J7D485, J7C477, J6L453, J6K639, J6K567, J6J613, J6H716, J6H630, J6B493, J6A679, J6A422, J5N567 ; Description: Heparin Sodium 1,000 units in 0.9% Sodium Chloride Injection USP, 500 mL and ; Drug Identification Number (DIN): 01935933.